Importantly, all tumor specimens were carrying a wild-type TP53 gene, retained ERα and GATA3 expression (Fig. 5b and Supplementary Fig. 5b), and have been previously shown to be estrogen responsive in vivo48. This evidence concerns the gene ESR1 and neoplasm.